Pharmafile Logo
Pharmafocus logo
Advanced Search

EU

Showing 15 posts of 243 posts found.

1200px-vaccine_image_1

GSK’s RSV vaccine approved in EU for older adults

June 7, 2023
Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine

GSK has announced that the European Commission (EC) has authorised Arexvy, the company’s respiratory syncytial virus (RSV) vaccine for active …

News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

European Parliament shares goal to tackle antimicrobial resistance

June 2, 2023
Medical Communications EU, European Parliament, Microbiology, antimicrobial resistance

The European Parliament has shared its recommendations for a “coordinated EU response to health threats posed by antimicrobial resistance,” according …

News

Is the pharmaceutical sector prepared to face a titanium dioxide ban?

May 19, 2023
Manufacturing and Production ACG, EMA, EU, Titanium Dioxide

Dr Subhashis Chakraborty, head of Global Product Management, ACG Capsules In the wake of the ban on titanium dioxide (TiO2) …

News
Press release

EMA validates HUTCHMED MAA for neuroendocrine tumour drug

July 16, 2021
Medical Communications EU, oncology

China-based biotech HUTCHMED has announced that the EMA has validated and accepted the Marketing Authorisation Application (MAA) for surufatinib, for …

News

Visitors with non-EU approved jabs allowed in Madeira

July 5, 2021
Sales and Marketing COVID-19, EU, Vaccine, travel

Popular holiday destination, the Portuguese islands of Madeira, have announced that they will allow visitors with any COVID-19 vaccine, even …

News
stock-incyte-01-shutter

CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab

June 29, 2021
Manufacturing and Production CHMP, EMA, EU, FDA, US

Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive …

News
biogen_austria_238

Samsung Bioepis & Biogen receive positive CHMP opinion for ranibizumab biosimilar

June 28, 2021
Sales and Marketing EC, EMA, EU, biosimilars

Samsung Bioepis and Biogen have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …

News
sanofi_hq__boetie_hall_small_

Sanofi’s NSCLC drug gains EC approval

June 25, 2021
Medical Communications EC, EU, NSCLC, Sanofi

The European Commission (EC) has approved Sanofi and Regeneron’s PD-1 inhibitor, Libtayo (cemiplimab), for the first-line treatment of adults with …

News

Exscientia buys Austrian cancer cell screening company for €50 million

June 17, 2021
AI, EU, deal, marketing, sales

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 million. The multimillion deal, paid …

News
img_4190-e1376666350337-web

MHRA approves venetoclax as acute myeloid leukemia treatment

June 8, 2021
Manufacturing and Production EC, EU, MHRA, leukemia

The MHRA has announced its approval for AbbVie’s venetoclax, in combination with a hypomethylating agent, for the treatment of newly …

News
covid_cell_1_20

MHRA confirms registration of Avacta’s lateral flow test

June 7, 2021
Sales and Marketing COVID-19, EU, MHRA, lateral flow test

Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …

News
moderna_norwood_plant

Moderna submits BLA with FDA for COVID vaccine

June 2, 2021
Research and Development COVID-19, EU, FDA, Lonza, Moderna, production

Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …

News
az

AstraZeneca’s lung cancer drug gains EU approval

May 28, 2021
Medical Communications AstraZeneca, EU, lung cancer, oncology

AstraZeneca’s Tagrisso (osimertinib) has been approved in the EU for the adjuvant treatment of adult patients with early-stage (IB, II …

News

BD unveils plan for €165 million Spanish manufacturing plant

May 19, 2021
Research and Development EU, manufacturing

BD has announced plans to build a new €160 million manufacturing plant in Zaragoza, located in the Aragon region of …

News

Sandoz announces €150 million investment in antibiotic production

May 18, 2021
Manufacturing and Production EU, manufacturing, production

Sandoz, a division of Novartis, has announced plans to develop its European antibiotics manufacturing network by expanding the production capabilities …

News

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023